Potentiation of antiaggregating effect of prostaglandins by α-tocopherol and quercetin
Authors:
- 1 August 2004
- journal article
- research article
- Published by Taylor & Francis in Platelets
- Vol. 15 (5) , 319-324
Abstract
Prostaglandin (PG) I2 (prostacyclin), PGE1 and their analogues are effective inhibitors of platelet aggregation. However, a clinical use of these compounds for the treatment of cardiovascular diseases is restricted due to unwanted side effects. α-Tocopherol and quercetin are weak antiplatelet agents. At the same time, they have mild if any side effects when consumed medicinally. The aim of this work was to study the possibility to decrease the effective antiplatelet concentrations of PGs combining them with α-tocopherol or quercetin. Platelet-rich plasma (PRP) was prepared from human blood. The inhibition of adenosine diphosphate-induced platelet aggregation was caused by PGs in the presence and absence of α-tocopherol or quercetin and corresponding concentration–effect curves were obtained. At a subthreshold concentration 200 and 2 μM, respectively, both α-tocopherol and quercetin essentially increased the antiplatelet effects of PGI2, PGE1 and iloprost. Especially effective was the combination of α-tocopherol with low concentrations of iloprost. Thus, combination of PGs with α-tocopherol or quercetin allows the use of prostaglandins at lower concentrations to inhibit platelet aggregation.Keywords
This publication has 21 references indexed in Scilit:
- The role of α-tocopherol in preventing disease: from epidemiology to molecular eventsMolecular Aspects of Medicine, 2003
- Vitamin E 80th Anniversary: A Double Life, Not Only Fighting RadicalsIUBMB Life, 2001
- Moderate supplementation with natural α-tocopherol decreases platelet aggregation and low-density lipoprotein oxidationAtherosclerosis, 1999
- α-Tocopherol Inhibits Aggregation of Human Platelets by a Protein Kinase C–Dependent MechanismCirculation, 1996
- Focus on prostacyclin and its novel mimeticsTrends in Pharmacological Sciences, 1996
- Review of the biology of quercetin and related bioflavonoidsFood and Chemical Toxicology, 1995
- The red wine phenolics trans-resveratrol and quercetin block human platelet aggregation and eicosanoid synthesis: Implications for protection against coronary heart diseaseClinica Chimica Acta, 1995
- Inhibition of platelet aggregation by some flavonoidsThrombosis Research, 1991
- Cyclic nucleotide phosphodiesterase inhibitors prevent aggregation of human platelets by raising cyclic amp and reducing cytoplasmic free calcium mobilizationThrombosis Research, 1987
- Vitamin E. An inhibitor of the platelet release reaction.Journal of Clinical Investigation, 1976